Nucleate Boston Announces Exclusive Legal Partnership with Mintz for Activator Program

Nucleate Boston, a nonprofit organization dedicated to empowering the next generation of biotech leaders, announces its partnership with Mintz, a leading law firm in the biotechnology sphere. Mintz will provide exclusive legal support to Nucleate Boston’s 2023 Activator program, which facilitates early-stage company formation in the life sciences. As noted by Mintz Life Sciences and Venture Capital and Emerging Companies Member <a href="https://www.mintz.com/our-people/joshua-d-fox" rel="noopener ugc nofollow" target="_blank">Josh Fox</a>, “Mintz is a leading law firm in the biotech space, advising companies on corporate transactions, intellectual property, regulatory matters and litigation, so this partnership makes perfect sense for us as a firm.” In describing the synergies between his practice and Nucleate, Josh commented, “My practice focuses on representing entrepreneurs and start-ups in the life sciences industry, so it’s a great match for me to be collaborating with Nucleate. In addition, I am excited to be working with the start-ups that are part of Nucleate and look forward to helping the entrepreneurs and founders that are part of the program.” <a href="https://nucleatehq.medium.com/nucleate-boston-announces-exclusive-legal-partnership-with-mintz-for-activator-program-744d9cdeadc7">Learn More</a>